Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 Trial

Isabelle Andrieux‐Meyer, Shahnaz Murad, Sombat Thanprasertsuk et al.|SSRN Electronic Journal|2020

Cited by 0